These bacteria also suppress inflammatory cytokines, including mRNA of NF-κB and IL-6 in the tumor microenvironment, and reduce CD4 + and CD206 + T cells in the spleen, contributing to an anti-tumor immune response [103]. The gene discussed is MRC1; the disease is neoplasm.